Pipeline Therapeutics Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Pipeline Therapeutics Inc. - overview
Established
2017
Location
San Diego, CA, US
Primary Industry
Biotechnology
About
Based in California, US, and founded in 2017, Pipeline Therapeutics Inc. operates as a biotechnology company that develops small molecules neuroregeneration that includes synaptogenesis, remyelination, and axonal repair. In 2018, Carmine Stengone was appointed as the president and CEO. Mr.
Stengone also served as the President & CEO of Avelas Biosciences, Senior Vice President, Business Development for COI Pharmaceuticals, Vice President of Corporate Development for Afraxis Holdings, co-founder and CEO of Afraxis, Inc. , Senior Director of Business Development of Phenomix Corporation, and serve a position in Anadys Pharmaceuticals and Johnson & Johnson Pharmaceutical Research and Development. The company is comprised of scientific & clinical advisors and scientist to develop PIPE-505, a small molecule gamma-secretase inhibitor (GSI) that treat mild-to-moderate sensorineural hearing loss (SNHL) associated with cochlear synaptopathy. It also develops PIPE-307, a neuro-generation process that focuses on remyelination and axonal repair that address a range of neurological disorders including multiple sclerosis.
The company also offers a portfolio of programs that provides treatment for neurological disorders and conditions. The company's revenue is generated by offering its product that focuses on small molecules in neuro-regeneration such as Synaptogenesis, Remyelination, and Axonal Repair.
Current Investors
Versant Ventures, Sectoral Asset Management, Hadean Ventures
Primary Industry
Biotechnology
Sub Industries
Biopharmaceuticals, Pharmaceutical Research & Development
Website
www.pipelinetherapeutics.com
Verticals
Manufacturing
Company Stage
Series C
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.